EGFR TKI–Based Combinations May Revolutionize Frontline EGFR+ NSCLC Management
Balazs Halmos, MD, discusses the FLAURA2 and MARIPOSA trials of EGFR TKIs plus chemotherapy in EGFR-mutated non–small cell lung cancer.
Source: onclive.com
Egfr Tkis News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Egfr Tkis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Egfr Tkis Today - Breaking & Trending Today
Continued Investigations are Pertinent for FDA Approvals in the Treatment of Patients With EGFR-mutated NSCLC
Jason Porter, MD, highlights the implications of recent data to emerge following the use of EGFR TKIs in the adjuvant setting, the importance of the potential upcoming FDA approval of osimertinib with chemotherapy in EGFR-positive non–small cell lung cancer, and more.
Source: onclive.com